166 related articles for article (PubMed ID: 10788488)
1. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases.
Kang YJ; Zhou ZX; Wang GW; Buridi A; Klein JB
J Biol Chem; 2000 May; 275(18):13690-8. PubMed ID: 10788488
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
Wang GW; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor necrosis factor-alpha-dependent cardiomyocyte apoptosis by metallothionein.
Klein JB; Wang GW; Zhou Z; Buridi A; Kang YJ
Cardiovasc Toxicol; 2002; 2(3):209-18. PubMed ID: 12665666
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
6. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of mitogen-activated protein kinases activation in vitro and in vivo.
Miao X; Tang Z; Wang Y; Su G; Sun W; Wei W; Li W; Miao L; Cai L; Tan Y; Liu Q
Toxicol Lett; 2013 Jul; 220(3):277-85. PubMed ID: 23664956
[TBL] [Abstract][Full Text] [Related]
9. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.
Rong J; Li L; Jing L; Fang H; Peng S
Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo.
Kaiser RA; Bueno OF; Lips DJ; Doevendans PA; Jones F; Kimball TF; Molkentin JD
J Biol Chem; 2004 Apr; 279(15):15524-30. PubMed ID: 14749328
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
Jing X; Yang J; Jiang L; Chen J; Wang H
Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
[TBL] [Abstract][Full Text] [Related]
12. Klotho Improves Cardiac Function by Suppressing Reactive Oxygen Species (ROS) Mediated Apoptosis by Modulating Mapks/Nrf2 Signaling in Doxorubicin-Induced Cardiotoxicity.
Zhu H; Gao Y; Zhu S; Cui Q; Du J
Med Sci Monit; 2017 Nov; 23():5283-5293. PubMed ID: 29107939
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
Wu HY; Kang YJ
J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
[TBL] [Abstract][Full Text] [Related]
14. Diallyl trisulfide suppresses doxorubicin-induced cardiomyocyte apoptosis by inhibiting MAPK/NF-κB signaling through attenuation of ROS generation.
Wen SY; Tsai CY; Pai PY; Chen YW; Yang YC; Aneja R; Huang CY; Kuo WW
Environ Toxicol; 2018 Jan; 33(1):93-103. PubMed ID: 29087013
[TBL] [Abstract][Full Text] [Related]
15. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
16. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice.
Kang YJ; Li Y; Sun X; Sun X
Am J Pathol; 2003 Oct; 163(4):1579-86. PubMed ID: 14507664
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels.
Wang GW; Kang YJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):938-44. PubMed ID: 10027829
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment.
Shuai Y; Guo JB; Peng SQ; Zhang LS; Guo J; Han G; Dong YS
Toxicol Lett; 2007 Apr; 170(1):66-74. PubMed ID: 17382496
[TBL] [Abstract][Full Text] [Related]
19. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
20. The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis.
Frias MA; Somers S; Gerber-Wicht C; Opie LH; Lecour S; Lang U
Cardiovasc Res; 2008 Oct; 80(1):69-77. PubMed ID: 18567640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
